SMTL ID : 4iwd.1

Structure of dually phosphorylated c-MET receptor kinase in complex with an MK-8033 analog

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.99 Å

Oligo State

monomer

Ligands

1 x 1JC: 1-{5-oxo-3-[1-(piperidin-4-yl)-1H-pyrazol-4-yl]-5H-benzo[4,5]cyclohepta[1,2-b]pyridin-7-yl}-N-(pyridin-2-ylmethyl)methanesulfonamide(Non-covalent)

1JC.1: 20 residues within 4Å: Chain A: I.38, G.39, R.40, G.41, H.42, V.46, A.62, K.64, L.94, L.111, P.112, Y.113, M.114, K.115, G.117, R.162, N.163, M.165, A.175, D.176 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:I.38, A:V.46, A:A.62, A:L.111, A:A.175 Hydrogen bonds: A:M.114 Water bridges: A:R.40 pi-Stacking: A:H.42

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Northrup, A.B. et al., Discovery of 1-[3-(1-methyl-1H-pyrazol-4-yl)-5-oxo-5H-benzo[4,5]cyclohepta[1,2-b]pyridin-7-yl]-N-(pyridin-2-ylmethyl)methanesulfonamide (MK-8033): A Specific c-Met/Ron dual kinase inhibitor with preferential affinity for the activated state of c-Met. J.Med.Chem. (2013)

Release Date

2013-12-11

Peptides

Hepatocyte growth factor receptor: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Hepatocyte growth factor receptor